Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014)

By  

Chemotherapy, Vol. 62, Iss. 1, 2016-05 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)

By Stefani Stefania   Dowzicky Michael J.  

Pharmaceuticals, Vol. 9, Iss. 4, 2016-11 ,pp. : 74-74

MDPI

Access to resources Recommend Favorite

Prospective, Non-Interventional, Multi-Centre Trial of Tigecycline in the Treatment of Severely Ill Patients with Complicated Infections – New Insights into Clinical Results and Treatment Practice

By  

Chemotherapy, Vol. 57, Iss. 4, 2011-07 ,pp. : 275-284

Karger

Access to resources Recommend Favorite

Surveillance of Antimicrobial Susceptibility among Bacterial Isolates from Intensive Care Unit Patients of a Tertiary-Care University Hospital in Iran: 2006–2009

By  

Chemotherapy, Vol. 56, Iss. 6, 2010-11 ,pp. : 478-484

Karger

Access to resources Recommend Favorite

Susceptibility of Staphylococcus aureus Clinical Isolates to Propolis Extract Alone or in Combination with Antimicrobial Drugs

By Wojtyczka Robert D.   Dziedzic Arkadiusz   Idzik Danuta   Kępa Małgorzata   Kubina Robert   Kabała-Dzik Agata   Smoleń-Dzirba Joanna   Stojko Jerzy   Sajewicz Mieczysław   Wąsik Tomasz J.  

Molecules, Vol. 18, Iss. 8, 2013-08 ,pp. : 9623-9640

MDPI

Access to resources Recommend Favorite